Reaktionsgleichung
[CH3:1][C:2]1[CH:3]=[CH:4][C:5](C2C=NC=CN=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8].Br[C:18]1[CH:23]=[CH:22][C:21]([CH3:24])=[CH:20][N:19]=1>>[CH3:1][C:2]1[CH:3]=[CH:4][C:5]([C:18]2[CH:23]=[CH:22][C:21]([CH3:24])=[CH:20][N:19]=2)=[C:6]([CH:10]=1)[C:7]([OH:9])=[O:8]Komponenten
3
Versuchsvorschrift
The title compound was synthesized following the same general protocol as described for 5-methyl-2-(pyrazin-2-yl)benzoic acid in Example A19, using 2-bromo-5-methylpyridine. ESI-MS (m/z): 228 [M+1]+.
Quellen und Nachweise
- ORD-Eintrag
- ord-2c3e2a4a70ce44ff85eaf6a7d8e61505
- Quelldatensatz
- uspto-grants-2016_09
- Patentnummer
- US09440982B2
Verknüpfte Notizen
Wird geladen…